Close Menu
Advertisement
Subscribe
[the_ad id="32629"]
Acute Lymphoblastic Leukemia

ASH 2015 Data Promises Immunotherapy Revolution in Multiple Myeloma with Pembrolizumab

Editor By No Comments1 Min Read

Frederic Reu, MD Taussig Cancer Institute, Department of Hematology & Medical Oncology Cleveland Clinic talks about new ASH 2015 Data That Promises Immunotherapy Revolution in Multiple Myeloma with Pembrolizumab

Share.

Related Posts